Management of S‐ICD lead in a patient requiring sternotomy
Key Clinical Message In patients who have had a prior subcutaneous ICD implanted, a sternotomy can be safely performed without the need for replacement of the ICD. Appropriate tools and closure technique during reimplantation are essential for this to be a possibility.
| Published in: | Clinical Case Reports |
|---|---|
| Main Authors: | Basil Saour, Rachel Kaplan, Austin Ward, Andrei Churyla, Susan Kim, Bradley Knight |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-07-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ccr3.2136 |
Similar Items
S-ICD Implantation "Tips and Tricks"
by: Szymon Budrejko, et al.
Published: (2023-07-01)
by: Szymon Budrejko, et al.
Published: (2023-07-01)
Subcutaneous implantable cardioverter defibrillator: Where do we stand?
by: Arindam Pande, et al.
Published: (2016-01-01)
by: Arindam Pande, et al.
Published: (2016-01-01)
Relevance of guideline-based ICD indications to clinical practice
by: Nora Al-Jefairi, et al.
Published: (2014-01-01)
by: Nora Al-Jefairi, et al.
Published: (2014-01-01)
Outcomes during and after the use of the wearable cardioverter-defibrillator in a tertiary-care and a regional hospital in Switzerland
by: Boldizsar Kovacs, et al.
Published: (2019-11-01)
by: Boldizsar Kovacs, et al.
Published: (2019-11-01)
A case report of a combined implantation technique of a cardioverter-defibrillator in an infant with long QT syndrome type 8 (Timothy's syndrome)
by: Sergei Viktorovich Nemtsov, et al.
Published: (2024-11-01)
by: Sergei Viktorovich Nemtsov, et al.
Published: (2024-11-01)
Comparison of Preoperative ECG Screening and Device-Based Vector Analysis in Patients Receiving a Subcutaneous Implantable Cardioverter-Defibrillator
by: Szymon Budrejko, et al.
Published: (2023-12-01)
by: Szymon Budrejko, et al.
Published: (2023-12-01)
Successful Implant of a Subcutaneous ICD System in a Patient with an Ipsilateral Epicardial Pacemaker
by: Paul S.G. Hong, MRCP, et al.
Published: (2015-01-01)
by: Paul S.G. Hong, MRCP, et al.
Published: (2015-01-01)
Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
by: Temirkhan Begisbayev, et al.
Published: (2022-05-01)
by: Temirkhan Begisbayev, et al.
Published: (2022-05-01)
Intraoperative Defibrillation Testing of Subcutaneous Implantable Cardioverter‐Defibrillator Systems—A Simple Issue?
by: Gerrit Frommeyer, et al.
Published: (2016-03-01)
by: Gerrit Frommeyer, et al.
Published: (2016-03-01)
A survey study of the use of a subcutaneous implantable cardioverter-defibrillator in various clinical scenarios by expert electrophysiologists in Poland
by: Maciej Kempa, et al.
Published: (2023-04-01)
by: Maciej Kempa, et al.
Published: (2023-04-01)
Subcutaneous Implantable Cardioverter Defibrillator: A Contemporary Overview
by: Fabrizio Guarracini, et al.
Published: (2023-07-01)
by: Fabrizio Guarracini, et al.
Published: (2023-07-01)
A cluster of inappropriate shocks in a pediatric S-ICD patient - how to troubleshoot?
by: Christina Menexi, et al.
Published: (2024-03-01)
by: Christina Menexi, et al.
Published: (2024-03-01)
Subcutaneous cardioverter-defibrillator, patient selection, implantation, postoperative management in the Krasnoyarsk
by: A. V. Prokopenko, et al.
Published: (2022-09-01)
by: A. V. Prokopenko, et al.
Published: (2022-09-01)
ICD Outcome in Pediatric Cardiomyopathies
by: Massimo Stefano Silvetti, et al.
Published: (2022-01-01)
by: Massimo Stefano Silvetti, et al.
Published: (2022-01-01)
Subcutaneous ICD implant complicated by an intraperitoneal lead course and device infection
by: Michael R. Kaufmann, MD, et al.
Published: (2016-05-01)
by: Michael R. Kaufmann, MD, et al.
Published: (2016-05-01)
Reduction of inappropriate shock rate through signal filtering (smart-pass) in patients with implantable subcutaneous cardioverter-defibrillator: a systematic review and meta-analysis
by: Maurizio Santomauro, et al.
Published: (2024-08-01)
by: Maurizio Santomauro, et al.
Published: (2024-08-01)
Perioperative Sensor and Algorithm Programming in Patients with Implanted ICDs and Pacemakers for Cardiac Resynchronization Therapy
by: Alexander Niedermeier, et al.
Published: (2021-12-01)
by: Alexander Niedermeier, et al.
Published: (2021-12-01)
Sudden Death Due to Thrombosis Associated with Implantable Cardioverter-Defibrillator Electrodes
by: Jose Maria Frutos Perez, et al.
Published: (2021-03-01)
by: Jose Maria Frutos Perez, et al.
Published: (2021-03-01)
Real world utilization and impact of the wearable cardioverter-defibrillator in a community setting
by: Aditi Naniwadekar, et al.
Published: (2017-05-01)
by: Aditi Naniwadekar, et al.
Published: (2017-05-01)
Long-term low-voltage impedance measurements in subcutaneous implantable cardioverter-defibrillators
by: Giacomo Mugnai, MD, PhD, et al.
Published: (2025-09-01)
by: Giacomo Mugnai, MD, PhD, et al.
Published: (2025-09-01)
Navigating the Uncommon: Case Report of Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Successfully Managed with Implantable Cardioverter Defibrillator (ICD)
by: Sidhi Laksono Purwowiyoto, et al.
Published: (2024-10-01)
by: Sidhi Laksono Purwowiyoto, et al.
Published: (2024-10-01)
IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)
by: L. A. Bokeria, et al.
Published: (2019-02-01)
IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)
by: L. A. Bokeria, et al.
Published: (2019-02-01)
Subcutaneous implantable cardioverter‐defibrillator: a systematic review of comparative effectiveness and safety
by: Sarah Wolf, et al.
Published: (2023-04-01)
by: Sarah Wolf, et al.
Published: (2023-04-01)
Intermuscular pocket for subcutaneous implantable cardioverter defibrillator: Single-center experience
by: Paola Ferrari, MD, et al.
Published: (2016-06-01)
by: Paola Ferrari, MD, et al.
Published: (2016-06-01)
Corrigendum: Predictors of late arrhythmic events after generator replacement in Brugada syndrome treated with prophylactic ICD
by: Federico Migliore, et al.
Published: (2022-11-01)
by: Federico Migliore, et al.
Published: (2022-11-01)
Implantable cardioverter defibrillators for primary prevention in cardiomyopathies
by: Vineetha Kanneganti, et al.
Published: (2024-03-01)
by: Vineetha Kanneganti, et al.
Published: (2024-03-01)
Application of ICD guidelines and indications in a community-based academic hospital: a case series-based discussion
by: WuQiang Fan, et al.
Published: (2014-04-01)
by: WuQiang Fan, et al.
Published: (2014-04-01)
Use of the wearable cardioverter-defibrillator – the Swiss experience
by: Boldizsar Kovacs, et al.
Published: (2020-09-01)
by: Boldizsar Kovacs, et al.
Published: (2020-09-01)
ICD in Cardiac Sarcoidosis: Variables Associated with Appropriate Therapy, Inappropriate Therapy, and Device Complications
by: Sebastian Mactaggart, et al.
Published: (2024-04-01)
by: Sebastian Mactaggart, et al.
Published: (2024-04-01)
Association of QTc Interval and V4-S Wave With Appropriate ICD Therapy in Hypertrophic Cardiomyopathy
by: Nixiao Zhang, et al.
Published: (2022-05-01)
by: Nixiao Zhang, et al.
Published: (2022-05-01)
Safety and Tolerability of Implanted Subcutaneous Cardioverter-Defibrillator Systems
by: A. V. Vereshchagina, et al.
Published: (2022-09-01)
by: A. V. Vereshchagina, et al.
Published: (2022-09-01)
The VDD ICD lead: Friend or Foe?
by: Suneet Mittal, MD
Published: (2020-07-01)
by: Suneet Mittal, MD
Published: (2020-07-01)
Real-World Efficacy and Safety of the Subcutaneous Implantable Cardioverter Defibrillator: Insights from the GASP Registry
by: Nikias Milaras, et al.
Published: (2025-06-01)
by: Nikias Milaras, et al.
Published: (2025-06-01)
Reassessment of practical usage and accumulation of real‐world data of wearable cardioverter defibrillator (WCD) in Japan—Design paper for J‐WCDR study
by: Shinichi Niwano, et al.
Published: (2021-02-01)
by: Shinichi Niwano, et al.
Published: (2021-02-01)
PREVENTION OF SUDDEN CARDIAC DEATH BY IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS: ANALYSIS OF LARGE-SCALE CLINICAL TRIALS AND RECOMMENDATIONS OF EUROPEAN SOCIETY OF CARDIOLOGY (2015)
by: N. V. Melnik
Published: (2018-01-01)
by: N. V. Melnik
Published: (2018-01-01)
Validation of ACC/AHA and ESC Sudden Cardiac Death Risk Guidelines in Diverse Hypertrophic Cardiomyopathy Cohort: Stratification HCM Study
by: Murillo Oliveira Antunes, et al.
Published: (2024-12-01)
by: Murillo Oliveira Antunes, et al.
Published: (2024-12-01)
Subcutaneous Implantable Cardioverter-defibrillator in Preventing Ventricular Arrhythmia and Sudden Cardiac Death – A Single-center Experience
by: Amarapalli Jayachandra, et al.
Published: (2024-08-01)
by: Amarapalli Jayachandra, et al.
Published: (2024-08-01)
Clinical outcomes of subcutaneous vs. transvenous implantable defibrillator therapy in a polymorbid patient cohort
by: Badder Kattih, et al.
Published: (2022-10-01)
by: Badder Kattih, et al.
Published: (2022-10-01)
Subcutaneous implantable cardioverter-defibrillator lead repositioning due to device sensing impairment in a patient with scoliosis
by: Mahsa Nourani, et al.
Published: (2023-01-01)
by: Mahsa Nourani, et al.
Published: (2023-01-01)
Similar Items
-
S-ICD Implantation "Tips and Tricks"
by: Szymon Budrejko, et al.
Published: (2023-07-01) -
Subcutaneous implantable cardioverter defibrillator: Where do we stand?
by: Arindam Pande, et al.
Published: (2016-01-01) -
Relevance of guideline-based ICD indications to clinical practice
by: Nora Al-Jefairi, et al.
Published: (2014-01-01) -
Outcomes during and after the use of the wearable cardioverter-defibrillator in a tertiary-care and a regional hospital in Switzerland
by: Boldizsar Kovacs, et al.
Published: (2019-11-01) -
A case report of a combined implantation technique of a cardioverter-defibrillator in an infant with long QT syndrome type 8 (Timothy's syndrome)
by: Sergei Viktorovich Nemtsov, et al.
Published: (2024-11-01)
